Lavena - Shumen Valuation Multiples

Lavena - Shumen is valued at $11M as of November 2026, a 0.8x revenue multiple. In the last fiscal year, Lavena - Shumen revenue was $15M and Lavena - Shumen EBITDA was $2M.

Lavena - Shumen Overview

About Lavena - Shumen

Lavena AD - Shumen is a Bulgarian cosmetic manufacturer. The company manufactures a variety of personal hygiene and skincare items, including creams, oils, shampoos, soaps, gels, wet wipes, toothpaste, and sprays. It operates under the brands Bebble, Maternea, Footness, Hands@Work, Sport Ready, and MyRose.


Founded

1962

HQ

Bulgaria

Employees

151

Website

lavena.bg

Financials (Last FY)

Revenue: $15M
EBITDA: $2M

EV

$11M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Lavena - Shumen Financials

Lavena - Shumen reported last fiscal year revenue of $15M and EBITDA of $2M.

In the same fiscal year, Lavena - Shumen generated $8M in gross profit, $2M in EBITDA, and $1M in net income.


Lavena - Shumen P&L

In the most recent fiscal year, Lavena - Shumen reported revenue of $15M and EBITDA of $2M.

Lavena - Shumen is profitable as of last fiscal year, with gross margin of 52%, EBITDA margin of 16%, and net margin of 8%.

See analyst estimates for Lavena - Shumen
Last FY202320242025202620272028
Revenue$15M$14M$15M$15M
Gross Profit$8M$7M$8M$8M
Gross Margin52%51%52%52%
EBITDA$2M$2M$3M$2M
EBITDA Margin16%18%18%16%
EBIT Margin10%9%11%10%
Net Profit$1M$978K$1M$1M
Net Margin8%7%9%8%
Net Debt$284K---

Financial data powered by Morningstar, Inc.

Lavena - Shumen Stock Performance

Lavena - Shumen has current market cap of $11M, and enterprise value of $11M.

Market Cap Evolution


Lavena - Shumen's stock price is $1.12.

Lavena - Shumen share price decreased by 7.9% in the last 30 days, and by 15.4% in the last year.

Lavena - Shumen has an EPS (earnings per share) of $0.12.

See more trading valuation data for Lavena - Shumen
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$11M$11M-0.1%-7.9%-9.8%-15.4%$0.12

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Lavena - Shumen Valuation Multiples

Lavena - Shumen trades at 0.8x EV/Revenue multiple, and 4.8x EV/EBITDA.

See NTM and 2027E valuation multiples for Lavena - Shumen

Lavena - Shumen Financial Valuation Multiples

As of November 19, 2026, Lavena - Shumen has market cap of $11M and EV of $11M.

Lavena - Shumen has a P/E ratio of 9.1x.

Last FY202320242025202620272028
EV/Revenue0.8x0.8x0.7x0.8x
EV/EBITDA4.8x4.5x3.9x4.8x
EV/EBIT7.3x8.5x6.5x7.3x
EV/Gross Profit1.4x1.5x1.4x1.4x
P/E9.1x11.4x8.6x9.1x
EV/FCF10.5x6.1x7.4x10.5x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Lavena - Shumen Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Lavena - Shumen Margins & Growth Rates

In the most recent fiscal year, Lavena - Shumen reported gross margin of 52%, EBITDA margin of 16%, and net margin of 8%.

See estimated margins and future growth rates for Lavena - Shumen

Lavena - Shumen Margins

Last FY20242025202720282029
Gross Margin52%52%52%
EBITDA Margin16%18%16%
EBIT Margin10%11%10%
Net Margin8%9%8%
FCF Margin7%10%7%

Lavena - Shumen Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth8%(4%)
Gross Profit Growth12%(4%)
EBITDA Growth13%(18%)
EBIT Growth30%(10%)
Net Profit Growth32%(5%)
FCF Growth(17%)(30%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Lavena - Shumen Operational KPIs

Lavena - Shumen's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.

Access forward-looking KPIs for Lavena - Shumen
Last FY202320242025202620272028
Revenue per Employee$0.1M---
Opex per Employee$0.0M---
S&M Expenses to Revenue4%4%4%4%
G&A Expenses to Revenue1%1%1%1%
Opex to Revenue42%41%41%42%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Lavena - Shumen Competitors

Lavena - Shumen competitors include Hain Celestial Group, EZZ Life Science, Big Tree Cloud Holdings, McPherson's, La savonnerie de Nyons, Cosma, Nuchev, Natural Health Trends, Skin Elements and Medicortex International.

Most Lavena - Shumen public comparables operate across Health & Beauty.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Hain Celestial Group$1.4B($197M)0.4x0.5x(2.9x)6.9x
EZZ Life Science$31M($4M)0.1x0.1x(0.7x)-
Big Tree Cloud Holdings$645K($3M)21.4x-(5.0x)-
McPherson's$80M($14M)0.2x0.2x(1.0x)3.0x
La savonnerie de Nyons$5M$1M1.3x-5.9x-
Cosma$4M($2M)3.6x-(6.4x)-
Nuchev$17M($4M)0.4x0.4x(1.7x)-
Natural Health Trends$40M($458K)----

This data is available for Pro users. Sign up to see all Lavena - Shumen competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Lavena - Shumen

See public comps similar to Lavena - Shumen

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial